DSM-5-defined ‘mixed features’ and Benazzi's mixed depression: Which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression?
Version of Record online: 14 JUL 2014
© 2014 The Authors. Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology
Psychiatry and Clinical Neurosciences
Volume 69, Issue 2, pages 109–116, February 2015
How to Cite
Takeshima, M. and Oka, T. (2015), DSM-5-defined ‘mixed features’ and Benazzi's mixed depression: Which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression?. Psychiatry and Clinical Neurosciences, 69: 109–116. doi: 10.1111/pcn.12213
- Issue online: 25 JAN 2015
- Version of Record online: 14 JUL 2014
- Accepted manuscript online: 6 JUN 2014 03:01AM EST
- Manuscript Accepted: 2 JUN 2014
- Manuscript Revised: 3 MAY 2014
- Manuscript Received: 10 MAR 2014
- Eli Lilly
- Meiji Seika Pharma
- bipolar disorder;
- mixed states;
- mixed depression
Irritability, psychomotor agitation, and distractibility in a major depressive episode (MDE) should not be counted as manic/hypomanic symptoms of DSM-5-defined mixed features; however, this remains controversial. The practical usefulness of this definition in discriminating bipolar disorder (BP) from major depressive disorder (MDD) in patients with depression was compared with that of Benazzi's mixed depression, which includes these symptoms.
The prevalence of both definitions of mixed depression in 217 patients with MDE (57 bipolar II disorder, 35 BP not otherwise specified, and 125 MDD cases), and their operating characteristics regarding BP diagnosis were compared.
The prevalence of both Benazzi's mixed depression and DSM-5-defined mixed features was significantly higher in patients with BP than it was in patients with MDD, with the latter being quite low (62.0% vs 12.8% [P < 0.0001], and 7.6% vs 0% [P < 0.0021], respectively). The area under the receiver operating curve for BP diagnosis according to the number of all manic/hypomanic symptoms was numerically larger than that according to the number of manic/hypomanic symptoms excluding the above-mentioned three symptoms (0.798; 95% confidence interval, 0.736–0.859 vs 0.722; 95% confidence interval, 0.654–0.790). The sensitivity/specificity of DSM-5-defined mixed features and Benazzi's mixed depression for BP diagnosis were 5.1%/100% and 55.1%/87.2%, respectively.
DSM-5-defined mixed features were too restrictive to discriminate BP from MDD in patients with depression compared with Benazzi's definition. To confirm this finding, studies that include patients with BP-I and using tools to assess manic/hypomanic symptoms during MDE are necessary.